Key result
A new protocol for managing heart valve patients with subtherapeutic INR tests provided significant improvements in patient care, but outcomes for clinic operating efficiency were mixed.
Why the study?
Does a standardized protocol for managing subtherapeutic INR improve patient outcomes and clinic efficiency in heart valve patients?
Does a standardized protocol for managing subtherapeutic INR improve patient outcomes and clinic efficiency in heart valve patients?
A standardized protocol for managing subtherapeutic INR in heart valve patients improved patient care but had mixed effects on clinic efficiency.
May warrant pilot expansion in valve clinics; leaves open efficiency trade-offs and adoption pending larger trials.
We sought to improve patient outcomes and efficiency in our anticoagulation clinic through development of a new protocol for managing heart valve patients with subtherapeutic international normalized ratio (INR) tests. The new protocol standardized use of 1 anticoagulation agent while warfarin was retitrated, timelines for INR retesting, and target INR levels depending on the type of valve implanted. The new protocol provided significant improvements in patient care; however, outcomes for clinic operating efficiency were mixed.
No takes yet. Share an insight, caveat, or question.
Carver et al. (2011) studied Heart valve patients with subtherapeutic INR tests. New protocol for managing subtherapeutic INR was evaluated on Patient outcomes and clinic operating efficiency. A new protocol for managing heart valve patients with subtherapeutic INR tests provided significant improvements in patient care, but outcomes for clinic operating efficiency were mixed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: